OXiGENE’s CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – In 2013 we have made good progress towards our goals by significantly enhancing our cash resources, by advancing ZYBRESTAT in ovarian cancer and other cancers and by advancing our earlier stage scientific … more

View todays social media effects on OXGN

View the latest stocks trending across Twitter. Click to view dashboard

See who OXiGENE is hiring next, click here to view